Claims
- 1. In a method of preparing nucleic acids comprising obtaining a sample containing cells and treating said sample with an extractant to lyse said cells and release nucleic acids, the improvement which comprises adding a cyclodextrin to the treated sample to neutralize the extractant.
- 2. The method as claimed in claim 1, wherein the extractant contains a surfactant.
- 3. The method as claimed in claim 2, wherein the surfactant is an anionic surfactant.
- 4. The method as claimed in claim 3, wherein the anionic surfactant is sodium dodecyl sulfonate.
- 5. The method as claimed in claim 1, wherein the nucleic acid is DNA.
- 6. The method as claimed in claim 1, wherein the nucleic acid is RNA.
- 7. The method of claim 1, further comprising enzymatically amplifying or restricting nucleic acids obtained from the treated sample containing cyclodextrin.
- 8. The method as claimed in claim 7, wherein the further processing is performed in the presence of the cyclodextrin.
- 9. The method as claimed in claim 1, wherein the cyclodextrin is used in stoichiometric excess over the extractant.
- 10. The method as claimed in claim 1, wherein the cyclodextrin is .alpha.-cyclodextrin.
- 11. A kit for nucleic acid manipulation comprising
- an extractant for treating cells to recover nucleic acid therefrom
- a cyclodextrin for neutralizing the extractant
- at least one polymerase or restriction enzyme for further processing the recovered nucleic acid by amplification or enzymatic modification or restriction.
- 12. In a method of preparing nucleic acids comprising obtaining an impure nucleic acid preparation and treating said preparation with phenol, the improvement which comprises adding a cyclodextrin to the treated preparation to neutralize the phenol.
- 13. The method as claimed in claim 12, wherein the nucleic acid is DNA.
- 14. The method of claim 12, further comprising enzymatically amplifying or restricting nucleic acids obtained from the treated preparation containing cyclodextrin.
- 15. The method as claimed in claim 14, wherein the further processing is performed in the presence of the cyclodextrin.
- 16. The method as claimed in claim 12, wherein the cyclodextrin is used in stoichiometric excess over the phenol.
- 17. The method as claimed in claim 12, wherein the cyclodextrin is .alpha.-cyclodextrin.
Priority Claims (1)
Number |
Date |
Country |
Kind |
9100551 |
Jan 1991 |
GBX |
|
Parent Case Info
This is a continuation-in-part of Ser. No. 08/347,228, filed Nov. 23, 1994, U.S. Pat. No. 5,558,986; which is a continuation of Ser. No. 08/075,484, filed Jun. 11, 1993, now abandoned; which is the U.S. national stage of PCT/GB92/00056, filed Jan. 10, 1992.
US Referenced Citations (5)
Foreign Referenced Citations (1)
Number |
Date |
Country |
0 301 847 |
Feb 1989 |
EPX |
Non-Patent Literature Citations (2)
Entry |
Baselski et al., Abstract presented at 92nd General Meeting of the American Society for Microbiology, May 1992. |
Loeffelholz et al., J. Clin. Microbiol. 30(11), 2847-2851 (Nov. 1992). |
Continuations (1)
|
Number |
Date |
Country |
Parent |
75484 |
Jan 1992 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
347228 |
Nov 1994 |
|